Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2014 by University of Cincinnati
Sponsor:
Collaborator:
Eli Lilly and Company
Information provided by (Responsible Party):
Melissa Delbello, University of Cincinnati
ClinicalTrials.gov Identifier:
NCT00845507
First received: February 16, 2009
Last updated: March 13, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2014
  Estimated Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)